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Abstract Knoevenagel condensation of barbituric acids
with aromatic aldehydes containing one or two formyl
groups was carried out. 5-Arylidenebarbituric acids under-
went smooth hetero-Diels-Alder (HDA) reactions with enol
ethers to afford cis and trans diastereoisomers of pyr-
ano[2,3-d]pyrimidine-2,4-diones and 5,50-(1,4-phenylene)-
bis[2H-pyrano[2,3-d]pyrimidine-2,4(3H)-dione] derivatives
in excellent yields (75–88 %). Syntheses were realized by
Knoevenagel condensation and HDA reaction in four dif-
ferent reaction conditions: Knoevenagel condensation in
water and Diels-Alder reaction in methylene chloride
solution, Knoevenagel condensation in water and Diels-
Alder reaction without solvent, three-component one-pot
reaction in methylene chloride solution, or three-compo-
nent one-pot reaction in water. All reactions were carried
out without catalyst at room temperature. The reactions of
malononitrile with Knoevenagel condensation products
of barbituric acids and heteroaromatic aldehydes or
terephthalaldehyde were examined and did not provide
corresponding pyranopyrimidines.
Keywords Cycloadditions  Drug research 
Michael addition  One-pot synthesis
Introduction
Pyran derivatives are common structural subunits in a variety
of important natural products, including carbohydrates,
alkaloids, polyether antibiotics, pheromones, and iridoids
[1, 2]. Uracil is one of the five nucleobases and therefore an
important component of nucleic acids. Uracil and its fused
derivatives, such as pyrano[2,3-d]pyrimidines, pyrido[2,3-d]-
pyrimidines, pyrazo[3,4-d]pyrimidines, or pyrimido[4,5-d]-
pyrimidines, are reported to have a wide range of biological
activities such as antiallergic [3], antihypertensive [4], car-
diotonic [5], bronchiodilator [6], antibronchitic [7], or
antitumor [8] activity. The preparation of the compounds
containing a pyran and an uracil ring poses significant syn-
thetic challenges. 3,4-Dihydro-2H-pyrans can be efficiently
synthesized by inverse-electron-demand hetero-Diels-Alder
(HDA) reactions of a,b-unsaturated carbonyl compounds
representing an 1-oxa-1,3-butadiene system with enol ethers
[9–11]. It has been stated that introducing an electron with-
drawing group in the 1-oxa-1,3-diene systems can enhance
their reactivity [12–15]. In our recent work, we showed that
intermolecular and intramolecular HDA reactions are a pow-
erful tool in the synthesis of 2H-pyran and polycyclic 2H-
pyran derivatives [16–24]. Also recently, as a continuation of
the investigations of organic reactions performed in aqueous
medium, a green approach to the synthesis of fused ura-
cils 2-thioxopyrano[2,3-d]pyrimidin-4-ones and pyrano[2,3-d]-
pyrimidin-2,4-diones was made. Three-component one-pot
syntheses of annulated uracils were performed in aqueous
suspensions by domino Knoevenagel/Diels-Alder reactions
without a catalyst and at room temperature [25]. In our last
work we also investigated inverse-electron demand Diels-
Alder cycloadditions of sterically hindered cycloalkylidene
derivatives of benzoyl acetonitrile and N,N0-dimethylbarbitu-
ric acid with enol ethers, cyclic enol ethers, and also sterically
hindered cycloalkylidenecycloalkanes [26]. Fused spiroura-
cils and fused dispirouracils can be obtained by this method.
The same a,b-unsaturated carbonyl compounds, obtained
by Knoevenagel condensation of the appropriate CH acids
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and aromatic aldehydes, can be used as substrates in pyran
synthesis by conjugate addition-cyclization with malono-
nitrile or cyanoacetate [27–29]. Pyrano[2,3-d]pyrimidine
derivatives can be prepared by conjugate addition-cycli-
zation of malononitrile to 5-arylidenebarbituric acids, or
general procedures include the reaction of arylidenemalo-
nonitriles with barbituric acids under traditional hot
reaction conditions [30, 31] or under microwave irradiation
[32]. Recently, the synthesis of pyrano[2,3-d]pyrimidines
by simply ball-milling a stoichiometric mixture of an
aldehyde, malononitrile, and barbituric acids without any
catalyst or solvent was described [33]. Also microwave-
assisted three-component cyclocondensation of aldehydes,
malononitrile, and barbituric acids proceeds in the absence
or presence of triethylamine to afford pyrano[2,3-d]-
pyrimidines [34]. Direct condensation of aldehydes, mal-
ononitrile, and barbituric acids in aqueous media has been
reported under heating [35] or under ultrasound irradiation
[36].
Therefore, 5-arylidene derivatives of barbituric acids
seem to be excellent intermediates in pyran synthesis both
by HDA reaction and by conjugate addition-cyclization.
Results and discussion
The main aim of the studies was the synthesis of new (1,4-
phenylene)bis[2H-pyrano[2,3-d]pyrimidine-2,4(3H)-dione]
derivatives containing two fused uracil moieties joined by a
benzene ring. Syntheses were realized by Knoevenagel
condensation and HDA reaction in four different reaction
conditions: A—Knoevenagel condensation in water and
HDA reaction in methylene chloride as solvent, B—
Knoevenagel condensation in water and HDA reaction
without solvent, C—three-component one-pot reaction in
methylene chloride as solvent, and D—three-component
one-pot reaction in water. All the reactions were carried out
at room temperature in the absence of catalyst.
First, procedures A–D were examined for the Knoeve-
nagel condensation of barbituric acids with aromatic
aldehydes containing only one formyl group and HDA
reactions with enol ether. 5-Arylidenebarbituric acids
3a–3c, as potential heterodienes in Diels-Alder reactions, were
synthesized by condensations of N,N0-dimethylbarbituric
acid (1a) or barbituric acid (1b) with aromatic aldehydes
2a–2c in water without catalyst and at room temperature
according the procedure described in the literature [37]
(Scheme 1). The condensations occurred smoothly and
were completed in just an hour, giving excellent yields
(95–98 %) of Knoevenagel products 3a–3c. The cycload-
dition reactions of 3a–3c with a tenfold excess of ethyl
vinyl ether 4 were performed with methylene chloride as
the solvent (conditions A) or in the absence of solvent
(conditions B) at room temperature for the time given in
Table 1. New 2H-pyrano[2,3-d]pyrimidine-2,4(3H)-diones
5a–5c were obtained in 77–88 % yields (Scheme 1;
Table 1). Next, three-component one-pot synthesis of
uracils 5a–5c by domino Knoevenagel/Diels-Alder reac-
tions was investigated in methylene chloride (conditions C)
or in aqueous medium (conditions D). The experimental
procedure was simple: equimolar amounts of barbituric
acid 1a or 1b and aromatic aldehyde 2a–2c were mixed
with a tenfold excess of enol ether 4 in methylene chloride
(conditions C) or in aqueous medium (conditions D)
(Scheme 1; Table 1). The progress of the reactions



















































































diastereoisomers of the pyrano[2,3-d]pyrimidine-2,4-di-
ones 5a–5c were determined on the basis of 1H NMR
spectra of the crude products, analyzing the signals of
protons 5-H and 7-H. The unexpected 5-methyl-substituted
derivatives of pyrano[2,3-d]pyrimidines 6a–6b were
obtained in aqueous medium (conditions D). This was
determined on the basis of the 1H NMR spectra of the
crude products. Formation of these compounds can be
explained as the result the three-component reaction of
barbituric acid 1a or 1b, the in situ generated acetaldehyde
and ethyl-vinyl ether 4. The addition of water to ether 4
catalyzed by barbituric acid provides a hemiacetal, which
undergoes ethanol elimination to produce the enol tautomer
or finally keto tautomer of acetaldehyde. Only compounds
cis-6a and trans-6a were separated in small amounts by
column chromatography.
All diastereoisomers of compounds 5a–5c were very easily
separated by column chromatography using t-butyl methyl
ether as an eluent because the difference between Rf (cis) and
Rf (trans) was approximately 0.2. Cycloadducts cis-5a–5c
were the major products in all reactions. Three-component
one-pot syntheses of pyrano[2,3-d]pyrimidines performed in
aqueous medium (conditions D) were faster than those exe-
cuted in dichloromethane or under solvent-free conditions,
and cis/trans selectivity was significantly improved.
In the second step of the studies, it was decided to test
the synthetic approach to the Knoevenagel condensation of
barbituric acid with an aromatic aldehyde containing two
formyl groups, terephthalaldehyde. HDA reactions with
enol ether were performed in conditions A–D. Condensa-
tion of N,N0-dimethylbarbituric acid with terephthalalde-
hyde (2d) was carried out in water without catalyst and at
room temperature, giving Knoevenagel product 3d with
97 % yield after 1 h (Scheme 2). It is worth noting that
there is only one synthetic method for this compound
described in the literature [38], but it required drastic
conditions, with acetic acid and sulfuric acid as the reactive
media. The cycloaddition reactions of 3d with a tenfold
excess of enol ethers 4a–4c were performed with methy-
lene chloride as the solvent (conditions A) or in the absence
of solvent (conditions B) at room temperature for the time
given in Table 2. Also three-component one-pot syntheses
of compounds 7a–7c by domino Knoevenagel/Diels-Alder
reactions were investigated in conditions C and D. Equi-
molar amounts of N,N0-dimethylbarbituric acid and 1,4-
benzenedicarbaldehyde were mixed with a tenfold excess
of enol ethers 4a–4c in methylene chloride (conditions C)
or in aqueous medium (conditions D) (Scheme 2; Table 2).
5,50-(1,4-Phenylene)bis[2H-pyrano[2,3-d]pyrimidine-2,4-
(3H)-dione] derivatives 7a–7c were obtained in 75–82 %
yields. The progress of the reactions was monitored by
TLC. The ratios of the cis/trans diastereoisomers of cyc-
loadducts 7a–7c were determined on the basis of 1H NMR
spectra of crude products, analyzing the signals of protons
5-H and 7-H. Cycloadducts cis-7a–7c were the major
products. The unexpected pyrano[2,3-d]pyrimidines 6a–6c
(conditions D) and 8a–8c (conditions C, D) were also
obtained in small amounts. It was determined on the
basis of the 1H NMR spectra of the crude products. For-
mation of compounds 6a–6c was explained above.
Cycloadducts 8a–8c were obtained as the result of Knoe-
venagel reaction of barbituric acid 1a and only one formyl
group of dicarbaldehyde 2d. Only compounds cis-6a,
trans-6a, cis-8a, and trans-8a were isolated by column
chromatography.
The three-component one-pot syntheses of pyrano
[2,3-d]pyrimidines 7a–7c performed in aqueous medium
(condition D) were faster than those executed in dichlo-
romethane or under solvent-free conditions, and cis/trans
selectivity was the highest for these reactions.
Compounds 5a–5c, 6a, 7a–7c, and 8a were character-
ized by 1H, 13C NMR, IR, and elemental analysis. 1H and
Table 1 Synthesis of the
cycloadducts 5a–5c by
Knoevenagel condensation and
HDA reaction in the reaction
conditions A–D
a Isolated yields after column
chromatography
b Ratio based on 1H NMR
(300 MHz) spectra of crude
products
Entry Method 1 R1 2 R2 3 5 6 Reaction
time/h
Yield/% of 5a Ratio of cis-5/
trans-5b
1 A 1a CH3 2a 4-BrC6H4 3a 5a – 15 87 1.8:1
2 B 1a CH3 2a 4-BrC6H4 3a 5a – 12 86 1.6:1
3 C 1a CH3 2a 4-BrC6H4 – 5a – 15 84 2.5:1
4 D 1a CH3 2a 4-BrC6H4 – 5a 6a 7 82 7.2:1
5 A 1a CH3 2b 4-ClC6H4 3b 5b – 13 81 2.3:1
6 B 1a CH3 2b 4-ClC6H4 3b 5b – 12 82 1.8:1
7 C 1a CH3 2b 4-ClC6H4 – 5b – 13 87 2.5:1
8 D 1a CH3 2b 4-ClC6H4 – 5b 6a 6 86 6.9:1
9 A 1b H 2c 4-H3COC6H4 3c 5c – 24 86 2.0:1
10 B 1b H 2c 4-H3COC6H4 3c 5c – 20 77 1.5:1
11 C 1b H 2c 4-H3COC6H4 – 5c – 22 82 2.2:1
12 D 1b H 2c 4-H3COC6H4 – 5c 6b 12 88 5.6:1
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13C signal assignments were confirmed by two-dimen-
sional COSY and HETCOR NMR spectra. The relative cis
and trans configuration of the C-5, C-7 substituents were
assigned on the basis of 1H NMR spectra. They were
deduced from the chemical shift values and coupling
constants of the protons attached to C-5 and C-7 of the
dihydropyran ring that exists in a half-chair conformation
(Table 3).
In the 1H NMR spectra of the major diastereoisomers
cis-5a–5c, cis-6a, cis-7a–7c, and cis-8a, the signal of
5-H (5-H and 50-H for cis-7a–7c) appeared as a doublet























































































Table 2 Synthesis of the
cycloadducts 7a–7c by
Knoevenagel condensation and
HDA reaction in the reaction
conditions A–D
a Isolated yields after column
chromatography
b Ratio based on 1H NMR
(300 MHz) spectra of crude
products
Entry Method 1 2 3 4 R1 R2 6 7 8 Reaction
time/h
Yield/% of 7a Ratio of cis-7/
trans-7b
1 A 1a 2d 3d 4a C2H5 H – 7a 8a 18 82 [100:1
2 B 1a 2d 3d 4a C2H5 H – 7a 8a 16 81 [100:1
3 C 1a 2d – 4a C2H5 H – 7a 8a 15 80 [100:1
4 D 1a 2d – 4a C2H5 H 6a 7a 8a 8 82 [100:1
5 A 1a 2d 3d 4b i-Bu H – 7b 8b 18 81 6.3:1
6 B 1a 2d 3d 4b i-Bu H – 7b 8b 17 78 5.9:1
7 C 1a 2d – 4b i-Bu H – 7b 8b 15 77 6.5:1
8 D 1a 2d – 4b i-Bu H 6b 7b 8b 8 76 8.1:1
9 A 1a 2d 3d 4c CH3 CH3 – 7c 8c 24 78 5.3:1
10 B 1a 2d 3d 4c CH3 CH3 – 7c 8c 20 75 5.5:1
11 C 1a 2d – 4c CH3 CH3 – 7c 8c 18 82 5.2:1
12 D 1a 2d – 4c CH3 CH3 6c 7c 8c 10 80 7.5:1
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d = 2.88 ppm) with coupling constants (3J = 6.9–7.5 and
4.8–6.3 Hz) because of coupling with two protons at C-6
(Table 3). Thus, 5-H (5-H and 50-H for cis-7a–7c) occupies
the pseudo-equatorial position, and the aromatic group
adopts the pseudo–axial orientation (Fig. 1). The 1H NMR
spectra of cis-5a–5c, cis-6a, cis-7a–7c, and cis-8a reveal
the signals of proton 7-H (7-H and 70-H for cis-7a–7c) as a
doublet of doublets at d = 5.07–5.42 ppm with two small
coupling constants 3J = 3.3–6.0 Hz (3J = 8.4 Hz only for
cis-7b) and 2.4–3.0 Hz. Thus, 7-H (7-H and 70-H for cis-
7a–7c) is in the equatorial position, and the alkoxy group
occupies the axial position (Fig. 1).
For the minor diastereoisomers trans-5a–5c, trans-6a,
trans-7a–7c, and trans-8a; the protons attached to C-5 (C-5
and C-50 for trans-7a–7c) give rise to a doublet of doublets
with coupling constants 3J = 5.4–11.7 and 3.9–6.6 Hz at
d = 3.81–4.20 ppm (for trans-6a, ddq d = 2.98 ppm).
Thus, 5-H (5-H and 50-H for trans-7a–7c) is pseudo-axial,
and the R2 moiety occupies the pseudo-equatorial position
(Fig. 1). The proton 7-H (7-H and 70-H for trans-7a–7c) of
trans-5a–5c, trans-6a, trans-7a–7c, and trans-8a resonates
at d = 5.08–5.32 ppm as a doublet of doublets with two
coupling constants (3J = 4.2–8.1 and 2.4–3.0 Hz). This
suggests that for trans-5a–5c, trans-6a, trans-7a–7c, and
trans-8a, the conformation with an axial alkoxy group is
preferred because of stabilization by the anomeric effect
(Fig. 1).
According to the literature, the Knoevenagel condensa-
tion products obtained by condensation of barbituric acids
and aromatic aldehydes are excellent reagents in pyran
synthesis by conjugate addition-cyclization [27–36]. There
is no information for the same reactions using heteroaro-
matic aldehydes or terephthalaldehyde. Therefore, in the
next step, the Michael addition-cyclization of malononitrile
with a,b-unsaturated carbonyl compounds obtained by
Knoevenagel condensation of barbituric acids and hetero-
aromatic aldehydes or terephthalaldehyde was examined.
The reactions of acids 1a, 1b with heteroaromatic alde-
hydes 2e, 2f in water at room temperature gave the
condensation products 3e and 3f with stoichiometric yields
after 1 h. Heating of 3e or 3f with malononitrile 9 under
reflux in water for 1 h (method E, Scheme 3; Table 4,
entries 1, 7, 13) or under reflux in acetonitrile in the
presence of piperidine for 3 h (method F, Scheme 3;
Table 4, entries 2, 8, 14) did not result in compounds 12.
Therefore, in the next step of the studies, the three-
component one-pot reactions of acids 1a, 1b, aldehydes 2e,
2f, and malononitrile 9 without solvent at 100 C (method
G, Scheme 3; Table 4, entries 3, 9, 15) or in water (method
H, Scheme 3; Table 4, entries 4, 10, 16) were examined.
There was no trace of the desired products 12 after 1 h of
heating, and compounds 3e–3g were obtained in excellent
85–93 % yields as the only products. Therefore, the next
attempts to synthesize the compounds 12 were undertaken.
Aldehydes 2e, 2f were first stirred with malononitrile 9 in
water at room temperature, and after 1 h the condensation
products 10a and 10b were isolated with stoichiometric
yields. Further, the mixture of compounds 10a, 10b was
Table 3 Signals of proton 5-H and 7-H in 1H NMR spectra of

































































































































Fig. 1 Preferred cis/trans configurations and conformations of cyc-
loadducts 5a–5c, 6a, 7a–7c, and 8a based on 1H NMR analysis
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Table 4 Reactions of barbituric
acids 1a, 1b, heteroaromatic
aldehydes 2e, 2f, and
malononitrile 9 in the reaction
conditions E–H
Entry Reagent R Reagent R Method Reagent R Product Yield/% of 3
10 3
1 1a CH3 2e 2-Thienyl E 9 – – 3e –
2 1a CH3 2e 2-Thienyl F 9 – – 3e –
3 1a CH3 2e 2-Thienyl G 9 – – 3e 89
4 1a CH3 2e 2-Thienyl H 9 – – 3e 93
5 2e 2-Thienyl 9 – E 1a CH3 10a 3e 91
6 2e 2-Thienyl 9 – F 1a CH3 10a 3e 85
7 1b H 2e 2-Thienyl E 9 – – 3f –
8 1b H 2e 2-Thienyl F 9 – – 3f –
9 1b H 2e 2-Thienyl G 9 – – 3f 85
10 1b H 2e 2-Thienyl H 9 – – 3f 89
11 2e 2-Thienyl 9 – E 1b H 10a 3f 90
12 2e 2-Thienyl 9 – F 1b H 10a 3f 81
13 1a CH3 2f 2-Furyl E 9 – – 3g –
14 1a CH3 2f 2-Furyl F 9 – – 3g –
15 1a CH3 2f 2-Furyl G 9 – – 3g 87
16 1a CH3 2f 2-Furyl H 9 – – 3g 90
17 2f 2-Furyl 9 – E 1a CH3 10b 3g 88
18 2f 2-Furyl 9 – F 1a CH3 10b 3g 79
11





















































































heated to reflux with barbituric acids 1a or 1b in water for
1 h (method E, Scheme 3; Table 4, entries 5, 11, 17) or
heated to reflux in acetonitrile in the presence of piperidine
for 3 h (method F, Scheme 3; Table 4, entries 6, 12, 18). In
these cases also, the only compounds, isolated in good
yields of 79–91 % after the reactions, were condensation
products 3e–3g. This result suggests that in the first step of
the reactions (Table 4, entries 5, 6, 11, 12, 17, 18), the
Michael adducts 11 are furnished (Scheme 3). Intermedi-
ates 11 did not undergo cyclization with formation of
pyrano[2,3-d]pyrimidine derivatives 12, but the elimination
of malononitrile led to undesired 3e–3g.
At the end of the study, the reaction procedures E–H
presented above were examined for acid 1a, terephthalal-
dehyde 2d, and malononitrile 9. The reaction of 1a with
aldehyde 2d in water at room temperature gave conden-
sation product 3d with almost stoichiometric yield after
1 h. When compound 3d was heated with malononitrile 9
in water for 1 h (method E, Scheme 4) or in acetonitrile in
the presence of piperidine for 3 h (method F, Scheme 4),
the expected compound 13 was not obtained.
However, when the three-component one-pot reactions
of acid 1a, aldehyde 2d, and malononitrile 9 were heated at
100 C (method G, Scheme 4) without solvent for 1 h or in
water under reflux (method H, Scheme 4), compound 3d
was obtained in excellent yield (87–91 %).
In conclusion, new fused uracils of possible pharmaco-
phore, the pyrano[2,3-d]pyrimidines and (1,4-phenylene)bis-
[2H-pyrano[2,3-d]pyrimidine-2,4(3H)-diones], were obtained
by domino Knoevenagel/Diels-Alder reactions in different
reaction conditions. All reactions were carried out without
catalyst and at room temperature. Three-component one-pot
syntheses of fused uracils performed in aqueous medium were
faster than those executed in dichloromethane or under
solventless conditions, and cis/trans selectivity was the
highest for these reactions. The reactions of malononitrile with
Knoevenagel condensation products of barbituric acids
and heteroaromatic aldehydes or terephthalaldehyde were
examined, and they do not provide corresponding pyranopyr-
imidines. The presented methods avoid the use of catalysts
and the heating of reaction mixtures for long times at
high temperatures, and the advantages of the presented
CH2(CN)2
(G) solventless, 100oC
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syntheses are also the excellent yields and short reactions
times.
Experimental
All chemicals were purchased and used without any further
purification. The melting points were determined on a
Boetius hot stage apparatus. The IR spectra were recorded
on a Nicolet IR 200 FT-IR, Thermo Scientific spectro-
photometer. NMR spectra were recorded on Bruker
Avance II 300 (1H: 300.18 MHz, 13C: 75.48 MHz) in
CDCl3 or DMSO-d6 with TMS as an internal standard.
Microanalyses were performed with a Euro EA 3000 Ele-
mental Analyzer; their results agreed satisfactorily with the
calculated values. 5-Arylidenebarbituric acids 3a–3g were
obtained according to the general procedure described in
Ref. [37].
Procedures for the synthesis of pyrano[2,3-d]-




A solution of 4.0 mmol 3a–3d (1.29 g 3a, 1.11 g 3b,
0.99 g 3c, 1.64 g 3d) in dry CH2Cl2 (50 cm
3 for 3a, 3b and
100 cm3 for 3c, 3d) and 40 mmol (10 equivalents) of enol
ethers 4a–4c (3.8 cm3 4a, 5.2 cm3 4b, 3.8 cm3 4c) was
kept at room temperature for the time given in Tables 1 or
2. The progress of the reactions was monitored by TLC.
The solvent and excess of ethers were evaporated, and the
mixture was separated and purified by column chroma-
tography on silica gel using t-butyl methyl ether as an
eluent. Recrystallization from a mixture of t-butyl methyl
ether and petroleum ether gave diastereoisomers 5a–5c,
7a–7c with yields listed in Tables 1 or 2.
Procedure B
A mixture of 4.0 mmol of one of the 5-arylidenebarbituric
acids 3a–3d (1.29 g 3a, 1.11 g 3b, 0.99 g 3c, 1.64 g 3d)
with a tenfold excess (40 mmol) of one of the enol ethers
4a–4c (3.8 cm3 4a, 5.2 cm3 4b, 3.8 cm3 4c) was stirred
without solvent at room temperature for the time given in
Tables 1 or 2. The progress of the reactions was monitored
by TLC. The excess of ethers was evaporated. Diastereo-
isomers were separated and recrystallized by the method
described in procedure A. Products 5a–5c, 7a–7c were
obtained with yields listed in Tables 1 or 2.
Procedure C
Equimolar amounts (4.0 mmol) of barbituric acid 1a
(0.625 g) or 1b (0.51 g) and aldehydes 2a–2d (0.74 g 2a,
0.56 g 2b, 0.5 cm3 2c, 0.27 g (2.0 mmol) 2d) were mixed
with a tenfold excess (40 mmol) of enol ethers 4a–4c
(3.8 cm3 4a, 5.2 cm3 4b, 3.8 cm3 4c) in 100 cm3 dry
CH2Cl2 at room temperature for the time given in Tables 1
or 2. The progress of the reactions was monitored by TLC.
The solvent and excess of ethers were evaporated, and the
mixture was separated and purified by the method descri-
bed in procedure A. Products 5a–5c, 7a–7c were obtained
with yields listed in Tables 1 or 2. The diastereoisomers of
product 8a were also separated and recrystallized in small
amounts.
Procedure D
A suspension of equimolar amounts (4.0 mmol) of barbi-
turic acid 1a (0.625 g) or 1b (0.51 g) and appropriate
aldehyde 2a–2d (0.74 g 2a, 0.56 g 2b, 0.5 cm3 2c, 0.27 g
(2.0 mmol) 2d) with a tenfold excess (40 mmol) of enol
ether 4a–4c (3.8 cm3 4a, 5.2 cm3 4b, 3.8 cm3 4c) in
50 cm3 H2O was allowed to stay under vigorous stirring at
room temperature for the time given in Tables 1 or 2. The
progress of the reactions was monitored by TLC. After
that, the reaction mixture was extracted with CH2Cl2. The
combined organic layers were dried (MgSO4), and the
solvent was evaporated under reduced pressure. Diastere-
oisomers were separated and recrystallized by the method
described in procedure A. Products 5a–5c, 7a–7c were
obtained with yields listed in Tables 1 or 2. Both diaste-
reoisomers of product 6a and product 8a were also




Colorless crystals; mp: 169–170 C; Rf = 0.48 (t-Bu-
OMe); IR (powder): m = 3,012, 2,926, 1,731, 1,664,
1,504, 1,190, 1,069, 1,017 cm-1; 1H NMR (300 MHz,
CDCl3): d = 1.13 (3H, t, J = 7.2 Hz, OCH2CH3), 2.14
(1H, ddd, J = 14.4, 5.1, 4.8 Hz, 6-H), 2.34 (1H, ddd,
J = 14.1, 7.5, 2.7 Hz, 6-H), 3.28 (3H, s, N-Me), 3.43 (3H,
s, N-Me), 3.58 (1H, dq, J = 9.3, 6.9 Hz, OCH2CH3), 3.86
(1H, dq, J = 9.3, 6.9 Hz, OCH2CH3), 4.00 (1H, dd,
J = 7.5, 5.1 Hz, 5-H), 5.38 (1H, dd, J = 4.8, 2.7 Hz,
7-H), 7.07 (2H, d, J = 8.4 Hz, Ar), 7.36 (2H, d,
J = 8.7 Hz, Ar) ppm; 13C NMR (75.5 MHz, CDCl3):
d = 14.9, 28.0, 28.7, 33.5, 35.4, 65.5, 89.0, 101.9, 119.9,




Colorless crystals; mp: 198–200 C; Rf = 0.65 (t-Bu-
OMe); IR (powder): m = 3,011, 2,964, 1,722, 1,651,
1,503, 1,171, 1,107, 1,017 cm-1; 1H NMR (300 MHz,
CDCl3): d = 1.26 (3H, t, J = 7.2 Hz, OCH2CH3), 2.07
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(1H, ddd, J = 13.8, 4.8, 2.4 Hz, 6-H), 2.20 (1H, ddd,
J = 13.8, 7.5, 6.3 Hz, 6-H), 3.29 (3H, s, N-Me), 3.43 (3H,
s, N-Me), 3.65 (1H, dq, J = 9.3, 6.9 Hz, OCH2CH3), 3.95
(1H, dq, J = 9.3, 6.9 Hz, OCH2CH3), 4.11 (1H, dd,
J = 5.7, 5.4 Hz, 5-H), 5.17 (1H, dd, J = 7.5, 2.4 Hz,
7-H), 7.06 (2H, d, J = 8.4 Hz, Ar), 7.42 (2H, d,
J = 8.4 Hz, Ar) ppm; 13C NMR (75.5 MHz, CDCl3):
d = 15.1, 28.0, 28.7, 33.6, 35.9, 66.0, 88.2, 101.2, 120.5,




Colorless crystals; mp: 141–142 C; Rf = 0.41 (t-Bu-
OMe); IR (powder): m = 2,992, 2,959, 2,887, 1,725,
1,654, 1,503, 1,280, 1,188, 1,046,1,016 cm-1; 1H NMR
(300 MHz, CDCl3): d = 1.13 (3H, t, J = 7.2 Hz,
OCH2CH3), 2.14 (1H, ddd, J = 14.4, 5.1, 4.8 Hz, 6-H),
2.33 (1H, ddd, J = 14.1, 7.5, 2.7 Hz, 6-H), 3.28 (3H, s,
N-Me), 3.43 (3H, s, N-Me), 3.58 (1H, dq, J = 9.3, 6.9 Hz,
OCH2CH3), 3.86 (1H, dq, J = 9.3, 6.9 Hz, OCH2CH3),
4.02 (1H, dd, J = 7.5, 5.1 Hz, 5-H), 5.38 (1H, dd, J = 4.5,
2.7 Hz, 7-H), 7.12 (2H, d, J = 8.4 Hz, Ar), 7.21 (2H, d,
J = 8.4 Hz, Ar) ppm; 13C NMR (75.5 MHz, CDCl3):
d = 14.9, 28.0, 28.7, 33.4, 35.4, 65.5, 89.1, 102.0, 128.2,




Colorless crystals; mp: 153–155 C; Rf = 0.59 (t-Bu-
OMe); IR (powder): m = 3,004, 2,960, 2,912, 2,887,
1,720, 1,651, 1,505, 1,178, 1,118, 1,035 cm-1; 1H NMR
(300 MHz, CDCl3): d = 1.27 (3H, t, J = 6.9 Hz,
OCH2CH3), 2.07 (1H, ddd, J = 14.1, 5.1, 2.7 Hz, 6-H),
2.20 (1H, ddd, J = 13.8, 7.5, 6.3 Hz, 6-H), 3.29 (3H, s,
N-Me), 3.43 (3H, s, N-Me), 3.65 (1H, dq, J = 9.3, 6.9 Hz,
OCH2CH3), 3.98 (1H, dq, J = 9.3, 6.9 Hz, OCH2CH3),
4.12 (1H, dd, J = 5.7, 5.1 Hz, 5-H), 5.17 (1H, dd, J = 7.8,
2.7 Hz, 7-H), 7.11 (2H, d, J = 8.4 Hz, Ar), 7.27 (2H, d,
J = 8.4 Hz, Ar) ppm; 13C NMR (75.5 MHz, CDCl3):
d = 15.1, 28.0, 28.7, 33.5, 36.0, 66.0, 88.3, 101.4, 128.6,




Colorless crystals; mp: 299–300 C; Rf = 0.39 (t-Bu-
OMe); IR (powder): m = 3,200, 3,170, 3,012, 2,938,
2,869, 1,732, 1,671, 1,530, 1,270, 1,200, 1,108, 1,068,
1,048 cm-1; 1H NMR (300 MHz, DMSO-d6): d = 1.00
(3H, t, J = 7.2 Hz, OCH2CH3), 1.92 (1H, ddd, J = 14.1,
4.8, 4.8 Hz, 6-H), 2.23 (1H, ddd, J = 14.1, 7.2, 2.4 Hz,
6-H), 3.50 (1H, dq, J = 9.6, 6.9 Hz, OCH2CH3), 3.69 (3H,
s, OCH3), 3.71 (1H, dq, J = 9.6, 7.2 Hz, OCH2CH3), 3.76
(1H, dd, J = 7.2, 4.8 Hz, 5-H), 5.41 (1H, dd, J = 4.5,
2.4 Hz, 7-H), 6.75 (2H, d, J = 9.0 Hz, Ar), 7.03 (2H, d,
J = 8.4 Hz, Ar), 10.69 (1H, s, NH), 11.35 (1H, s, NH)
ppm; 13C NMR (75.5 MHz, DMSO-d6): d = 14.8, 31.4,
35.4, 54.8, 64.1, 87.8, 100.6, 112.8, 128.2, 136.3, 150.0,




Colorless crystals; mp: 314–315C; Rf = 0.65 (t-BuOMe);
IR (powder): m = 3,192, 3,120, 3,003, 2,958, 2,884, 2,851,
1,725, 1,632, 1,529, 1,260, 1,186, 1,088, 1,045 cm-1; 1H
NMR (300 MHz, DMSO-d6): d = 1.13 (3H, t, J = 7.2 Hz,
OCH2CH3), 1.94 (1H, ddd, J = 13.8, 4.5, 2.4 Hz, 6-H),
2.07 (1H, ddd, J = 13.8, 8.1, 6.0 Hz, 6-H), 3.61 (1H, dq,
J = 9.6, 6.9 Hz, OCH2CH3), 3.71 (3H, s, OCH3), 3.81
(1H, dd, J = 5.4, 4.8 Hz, 5-H), 3.84 (1H, dq, J = 9.6,
6.9 Hz, OCH2CH3), 5.08 (1H, dd, J = 8.1, 2.4 Hz, 7-H),
6.83 (2H, d, J = 8.7 Hz, Ar), 7.08 (2H, d, J = 8.7 Hz, Ar)
10.72 (1H, s, NH), 11.38 (1H, s, NH) ppm; 13C NMR
(75.5 MHz, DMSO-d6): d = 14.9, 31.8, 36.0, 54.9, 64.8,





Colorless crystals; mp: 79–80 C; Rf = 0.37 (t-BuOMe);
IR (powder): m = 2,968, 2,934, 2,901, 2,879, 1,701, 1,625,
1,483, 1,183, 1,144, 1,102, 1,022 cm-1; 1H NMR
(300 MHz, CDCl3): d = 1.26 (3H, t, J = 7.2 Hz,
OCH2CH3), 1.35 (3H, d, J = 6.9 Hz, 5-CH3), 1.90 (1H,
ddd, J = 14.1, 3.6, 3.3 Hz, 6-H), 2.05 (1H, ddd, J = 14.1,
6.9, 3.0 Hz, 6-H), 2.88 (1H, ddq, J = 6.9, 6.9, 3.6 Hz,
5-H), 3.34 (3H, s, N-Me), 3.36 (3H, s, N-Me), 3.65 (1H, dq,
J = 9.3, 6.9 Hz, OCH2CH3), 3.89 (1H, dq, J = 9.3,
7.2 Hz, OCH2CH3), 5.40 (1H, dd, J = 3.3, 3.0 Hz, 7-H)
ppm; 13C NMR (75.5 MHz, CDCl3): d = 15.1, 20.1, 22.6,





Colorless crystals; mp: 88–90 C; Rf = 0.43 (t-BuOMe);
IR (powder): m = 2,972, 2,931, 2,908, 2,883, 1,701, 1,630,
1,491, 1,182, 1,140, 1,098, 1,020 cm-1; 1H NMR
(300 MHz, CDCl3): d = 1.26 (3H, d, J = 6.9 Hz,
5-CH3), 1.31 (3H, t, J = 7.2 Hz, OCH2CH3), 1.85 (1H,
ddd, J = 13.8, 3.9, 2.7 Hz, 6-H), 1.94 (1H, ddd, J = 13.8,
8.1, 6.0 Hz, 6-H), 2.98 (1H, ddq, J = 6.9, 6.9, 3.9 Hz,
5-H), 3.33 (3H, s, N-Me), 3.35 (3H, s, N-Me), 3.73 (1H, dq,
Synthesis of fused uracils 1183
123
J = 9.6, 7.2 Hz, OCH2CH3), 4.01 (1H, dq, J = 9.6,
7.2 Hz, OCH2CH3), 5.30 (1H, dd, J = 8.1, 2.7 Hz, 7-H)
ppm; 13C NMR (75.5 MHz, CDCl3): d = 15.1, 20.8, 23.2,





Colorless crystals; mp:[360 C; Rf = 0.14 (t-BuOMe); IR
(powder): m = 2,973, 2,926, 2,884, 1,703, 1,635, 1,480,
1,173, 1,132, 1,035, 1,001 cm-1; 1H NMR (300 MHz,
CDCl3): d = 1.15 (3H, t, J = 7.2 Hz, OCH2CH3), 2.17
(2H, ddd, J = 14.7, 6.3, 5.7 Hz, 6-H, 60-H), 2.32 (2H, ddd,
J = 14.1, 7.2, 2.7 Hz, 6-H, 60-H), 3.27 (6H, s, N-Me), 3.42
(6H, s, N-Me), 3.58 (2H, dq, J = 9.3, 6.9 Hz, OCH2CH3),
3.86 (2H, dq, J = 9.3, 7.2 Hz, OCH2CH3), 4.00 (2H, dd,
J = 7.2, 6.3 Hz, 5-H, 50-H), 5.31 (2H, dd, J = 5.7, 2.7 Hz,
7-H, 70-H), 7.05 (4H, br, Ar) ppm; 13C NMR (75.5 MHz,
CDCl3): d = 14.9, 27.9, 28.7, 34.0, 36.1, 65.5, 90.0, 102.5,




Colorless crystals; mp:[360 C; Rf = 0.24 (t-BuOMe); IR
(powder): m = 2,959, 2,927, 2,864, 2,853, 1,702, 1,636,
1,458, 1,162, 1,154, 1,047, 1,006 cm-1; 1H NMR
(300 MHz, CDCl3): d = 0.90 (12H, d, J = 6.6 Hz, OCH2
CH(CH3)2), 1.67 (2H, m, OCH2CH(CH3)2), 2.02 (2H, ddd,
J = 13.8, 4.8, 2.4 Hz, 6-H, 60-H), 2.20 (2H, ddd, J = 13.8,
8.4, 6.0 Hz, 6-H, 60-H), 3.30 (6H, s, N-Me), 3.41 (6H, s,
N-Me), 3.54 (1H, dd, J = 9.0, 6.3 Hz, OCH2CH
(CH3)2), 3.67 (1H, dd, J = 9.0, 6.6 Hz, OCH2CH(CH3)2),
3.99 (1H, dd, J = 7.5, 6.0 Hz, 5-H), 4.03 (1H, dd, J = 6.9,
5.4 Hz, 50-H), 5.07 (1H, dd, J = 6.0, 2.4 Hz, 7-H), 5.11
(1H, dd, J = 8.4, 3.0 Hz, 70-H), 7.00 (2H, br, Ar), 7.05
(2H, br, Ar) ppm; 13C NMR (75.5 MHz, CDCl3): d =
19.0, 19.5, 27.8, 28.3, 28.5, 33.5, 33.7, 36.0, 36.1, 77.2,





Colorless crystals; mp:[360 C; Rf = 0.37 (t-BuOMe); IR
(powder): m = 2,955, 2,921, 2,868, 2,851, 1,699, 1,634,
1,455, 1,166, 1,151, 1,053, 1,002 cm-1; 1H NMR
(300 MHz, CDCl3): d = 0.91 (12H, d, J = 6.9 Hz,
OCH2CH(CH3)2), 1.83 (2H, m, OCH2CH(CH3)2), 2.13
(2H, ddd, J = 13.8, 8.7, 3.9 Hz, 6-H, 60-H), 2.28 (2H, ddd,
J = 13.8, 5.7, 4.8 Hz, 6-H, 60-H), 3.29 (6H, s, N-Me), 3.40
(6H, s, N-Me), 3.58 (1H, dd, J = 9.0, 6.3 Hz,
OCH2CH(CH3)2), 3.65 (1H, dd, J = 9.0, 6.6 Hz, OCH2CH
(CH3)2), 4.12 (1H, dd, J = 9.3, 4.8 Hz, 5-H), 4.19 (1H, dd,
J = 5.4, 3.9 Hz, 50-H), 5.28 (1H, dd, J = 5.7, 2.4 Hz,
7-H), 5.32 (1H, dd, J = 4.2, 3.0 Hz, 70-H), 7.00 (2H, br,
Ar), 7.05 (2H, br, Ar) ppm; 13C NMR (75.5 MHz, CDCl3):
d = 19.1, 19.2, 28.0, 28.6, 28.7, 33.6, 33.7, 35.4, 35.5,
77.2, 89.2, 90.0, 102.6, 103.0, 126.8, 126.9, 140.8, 141.0,




Colorless crystals; mp:[360 C; Rf = 0.27 (t-BuOMe); IR
(powder): m = 2984, 2958, 2887, 1700, 1627, 1485, 1455,
1176, 1072, 1042, 1019 cm-1; 1H NMR (300 MHz,
CDCl3): d = 1.53 (3H, s, 7-CH3), 1.56 (3H, s, 70-CH3),
2.11 (2H, dd, J = 14.1, 7.2 Hz, 6-H, 60-H), 2.31 (2H, dd,
J = 14.1, 6.0 Hz, 6-H, 60-H), 3.19 (6H, s, OCH3), 3.29
(6H, s, N-Me), 3.42 (6H, s, N-Me), 3.97 (2H, dd, J = 7.2,
5.1 Hz, 5-H), 7.03 (4H, br, Ar) ppm; 13C NMR (75.5 MHz,
CDCl3): d = 22.3, 27.9, 28.6, 34.3, 39.8, 49.6, 88.9, 105.6,




Colorless crystals; mp:[360 C; Rf = 0.39 (t-BuOMe); IR
(powder): m = 2,981, 2,952, 2,885, 1,697, 1,631, 1,486,
1,449, 1,172, 1,069, 1,047, 1,018 cm-1; 1H NMR
(300 MHz, CDCl3): d = 1.53 (3H, s, 7-CH3), 1.55 (3H,
s, 70-CH3), 2.12 (2H, dd, J = 14.4, 11.4 Hz, 6-H, 6
0-H),
2.33 (2H, dd, J = 14.4, 6.9 Hz, 6-H, 60-H), 3.23 (6H, s,
OCH3), 3.31 (6H, s, N-Me), 3.42 (6H, s, N-Me), 3.93 (2H,
dd, J = 11.7, 6.6 Hz, 5-H, 50-H), 7.02 (4H, br, Ar) ppm;
13C NMR (75.5 MHz, CDCl3): d = 22.1, 27.8, 28.5, 34.2,





Colorless crystals; mp: 335–337 C; Rf = 0.19 (t-Bu-
OMe); IR (powder): m = 2,975, 2,937, 2,898, 1,703,
1,634, 1,571, 1,486, 1,379, 1,170, 1,092, 1,004 cm-1; 1H
NMR (300 MHz, CDCl3): d = 1.26 (3H, t, J = 7.2 Hz,
OCH2CH3), 2.22 (1H, ddd, J = 14.1, 4.8, 4.5 Hz, 6-H),
2.38 (1H, ddd, J = 14.4, 7.5, 2.7 Hz, 6-H), 3.28 (3H, s,
N-Me), 3.45 (3H, s, N-Me), 3.57 (1H, dq, J = 9.3, 6.9 Hz,
OCH2CH3), 3.84 (1H, dq, J = 9.3, 7.2 Hz, OCH2CH3),
4.13 (1H, dd, J = 7.5, 5.1 Hz, 5-H), 5.42 (1H, dd, J = 4.5,
2.7 Hz, 7-H), 7.36 (2H, d, J = 8.4 Hz, Ar), 7.78 (2H, d,
J = 8.4 Hz, Ar), 9.95 (1H, s, CHO) ppm; 13C NMR
(75.5 MHz, CDCl3): d = 14.8, 28.0, 28.8, 33.9, 35.0, 66.5,







Colorless crystals; mp: 168–170 C; Rf = 0.29 (t-Bu-
OMe); IR (powder): m = 2,951, 2,898, 2,823, 2,732,
1,698, 1,634, 1,574, 1,488, 1,169, 1,118, 1,043,
1,005 cm-1; 1H NMR (300 MHz, CDCl3): d = 1.26 (3H,
t, J = 7.2 Hz, OCH2CH3), 2.09 (1H, ddd, J = 13.8, 6.0,
2.4 Hz, 6-H), 2.27 (1H, ddd, J = 13.8, 7.2, 6.6 Hz, 6-H),
3.28 (3H, s, N-Me), 3.44 (3H, s, N-Me), 3.67 (1H, dq,
J = 9.3, 6.9 Hz, OCH2CH3), 3.95 (1H, dq, J = 9.6,
7.2 Hz, OCH2CH3), 4.20 (1H, dd, J = 6.3, 6.0 Hz, 5-H),
5.24 (1H, dd, J = 6.9, 2.4 Hz, 7-H), 7.37 (2H, d,
J = 8.1 Hz, Ar), 7.83 (2H, d, J = 8.4 Hz, Ar), 9.97 (1H,
s, CHO) ppm; 13C NMR (75.5 MHz, CDCl3): d = 15.0,
28.0, 28.7, 34.2, 35.9, 66.0, 88.3, 100.9, 127.9, 130.2,
135.2, 151.1, 151.2, 155.4, 162.0, 191.7 ppm.
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